ADAMTS9 and neoplasm: qRT-PCR analysis of xenograft tumor samples showed that the ADAMTS9-AS2–overexpressing group had higher levels of differentiation markers (Syn and Tau) and lower levels of MYCN and stem cell markers (Nestin and SOX2) compared with SK-N-Be2 cell xenograft vehicle groups (Figure 7B).